Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- ChecktodayChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check50 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check64 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
- Check69 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.1%
Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.